TIGIT and colorectal cancer: Similarly, T cell dysfunction in colorectal cancer has been related to diminished glucose metabolism since TIGIT expression, and metabolic alterations induced by colorectal cancer cells are restored by antibody-mediated TIGIT blockade (245).